AAK1 and COVID-19: The results showed that compared with normal subjects, the expression levels of AAK1 and TMPRSS2 in patients who had been infected with SARS-CoV-2 were significantly down-regulated, suggesting that COVID-19 patients may consume lots of AAK1 and TMPRSS2 in the advanced stage of the disease.